The Defense Logistics Agency Troop Support Medical awarded a $42,743.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 bottles of the 5 mg tablet formulation of INLYTA, an oncology medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 3rd and July 25th, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for cancer treatment...
The Defense Logistics Agency Troop Support Medical awarded a $10,710.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of 1 mg INLYTA, an oncology medication. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply chain programs. No major subcontractors or set aside designations were indicated. The delivery order was issued under an...
The Defense Logistics Agency Troop Support Medical awarded a $21,422 delivery order to Amerisourcebergen Drug Corporation for 180 tablets of the 1 mg dosage of INLYTA, an oncology drug. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania over a period concluding on September 8, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill this requirement to supply pharmaceuticals in support of the Defense Logistics Agency's mission to...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,685.92 to Amerisourcebergen Drug Corporation to supply 60 boxes of 5 mg INLYTA tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 12, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. No set-aside designation or subcontractors were identified. The Defense Logistics...
The Defense Logistics Agency Troop Support Medical awarded a $32,132.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of the 1 mg dosage of INLYTA, an oncology drug. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 8, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, procuring pharmaceuticals...
The Defense Logistics Agency awarded a $21,397 delivery order to Amerisourcebergen Drug Corporation for 180 tablets of the drug INLYTA at 1 mg each. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide cancer treatment medications to DLA and its customer bases. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four week period concluding in mid-September. No subcontractors or set aside...
The Defense Logistics Agency Troop Support Medical awarded a $42,843.84 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 180 tablets of the 1 mg dosage of INLYTA, an oncology pharmaceutical. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 18, 2023 and ending on October 10, 2023. No major subcontractors or set aside designations...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $21,421.92. The delivery order is for 180 tablets of the 1 mg strength of INLYTA, an oral medication used to treat advanced kidney cancer. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by January 2, 2024. No set-aside designation...
The Defense Logistics Agency awarded a $10,685.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 60 INLYTA 5 MG tablets. INLYTA is an oral kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. The place of performance for this order is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is approximately three weeks, from June 22, 2023 through July 14, 2023. No set aside designation or...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $85,487.36 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561866917 INLYTA 5 MG tablets. The contract has a period of performance from August 18, 2023 through September 11, 2023. INLYTA is an oral medication used to treat advanced renal cell carcinoma. Under this delivery order, Amerisourcebergen will provide approximately 60,000 INLYTA tablets...